Search research articles

Search research articles

Related Experiment Videos

Methodological issues and new developments in the economic evaluation of vaccines.

Philippe Beutels¹, Eddy Van Doorslaer, Pierre Van Damme

¹National Center for Immunisation Research and Surveillance, University of Sydney and Center for Health Economics Research and Evaluation, Australia.

Expert Review of Vaccines

|January 9, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Emergency department longitudinal integrated care (EDLINC) study: Protocol for a pragmatic effectiveness randomized clinical trial.

Contemporary clinical trials·2026

Same author

Reducing Hyperoxemia in Mechanically Ventilated Emergency Department Patients: A Before-and-After Study.

The Journal of emergency medicine·2026

Same author

Cost-Effective Threshold Price for Alternative Infant and Neonatal Rotavirus Vaccines: A Dual-Country Evaluation.

medRxiv : the preprint server for health sciences·2026

Same author

Estimating EQ-5D-5L quality-adjusted life year weights from GHQ-12 mental health data: a large sample exploration of four mapping methods.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Same author

Prevalence of hepatitis B surface antibodies and hepatitis B exposure in Belgium: results from a nationwide population-based serosurvey.

BMC infectious diseases·2026

Same author

Comparative analysis of the impact of chickenpox and herpes zoster vaccination in Belgium under two different exogenous boosting mechanisms.

PloS one·2026

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Economic evaluation of vaccination programs faces challenges in modeling, predicting uptake, and valuing benefits. Future developments aim for more sophisticated and accurate economic models for vaccines.

Area of Science:

Health economics
Vaccinology
Epidemiological modeling

Background:

Economic evaluation in healthcare, particularly for vaccination programs, has grown significantly since the 1980s.
Analyzing vaccine programs presents unique challenges for economic assessment.

Purpose of the Study:

To highlight key challenges in the economic evaluation of vaccination programs.
To identify areas for future development in vaccine economic modeling.

Main Methods:

Review of challenges in economic evaluation of vaccine programs.
Discussion of epidemiological modeling, uptake rate prediction, quality-adjusted survival gains, and intangible costs/benefits.
Analysis of marginal intervention costs and discount rate selection.

Related Experiment Videos

Main Results:

Key challenges include developing accurate epidemiological models, predicting vaccine uptake, incorporating quality-adjusted life years, and valuing intangible benefits.
Estimating marginal costs for multivalent vaccines and selecting appropriate discount rates for long-term cost-benefit analysis are particularly difficult.
Current methods require sophisticated approaches to accurately capture the full economic impact of vaccination.

Conclusions:

Economic evaluation of vaccines requires addressing complex methodological issues.
Advancements in the next five years are expected to yield more sophisticated and accurate models for assessing vaccination programs.
Improved economic models will enhance decision-making for healthcare resource allocation in immunization initiatives.